141 related articles for article (PubMed ID: 870007)
1. Specific interaction of HLA antibodies (eluates) with washed platelets.
Heinrich D; Stephinger U; Mueller-Eckhardt C
Br J Haematol; 1977 Mar; 35(3):441-52. PubMed ID: 870007
[TBL] [Abstract][Full Text] [Related]
2. Alloantibody-induced platelet serotonin release is blocked by antibody to the platelet PLA1 antigen.
Duncan JR; Rosse WF
Br J Haematol; 1986 Oct; 64(2):331-8. PubMed ID: 3778827
[TBL] [Abstract][Full Text] [Related]
3. A comparative analysis of methods suitable for detection of platelet alloantibodies: inhibition of 14C-serotonin uptake, 14C-serotonin release and microcomplement fixation.
Heinrich D; Kessler C; Mueller-Eckhardt CM
Vox Sang; 1977; 32(6):325-34. PubMed ID: 898831
[TBL] [Abstract][Full Text] [Related]
4. HLA (class I) antigens on platelets are involved in platelet function.
Cosgrove LJ; Vaughan HA; Tjandra JJ; Thurlow PJ; McKenzie IF
Immunol Cell Biol; 1988 Feb; 66 ( Pt 1)():69-77. PubMed ID: 3372006
[TBL] [Abstract][Full Text] [Related]
5. Platelet interaction with subendothelial extracellular matrix: platelet-fibrinogen interactions are essential for platelet aggregation but not for the matrix-induced release reaction.
Eldor A; Vlodavsky I; Martinowicz U; Fuks Z; Coller BS
Blood; 1985 Jun; 65(6):1477-83. PubMed ID: 3995180
[TBL] [Abstract][Full Text] [Related]
6. Effects of cephalothin and penicillin G on platelet function in vitro.
Cazenave J-P ; Guccione MA; Packham MA; Mustard JF
Br J Haematol; 1977 Jan; 35(1):135-52. PubMed ID: 869992
[TBL] [Abstract][Full Text] [Related]
7. Plasmin inhibition of thrombin-induced platelet aggregation.
Miller JL; Katz AJ; Feinstein MB
Thromb Diath Haemorrh; 1975 Apr; 33(2):286-309. PubMed ID: 124475
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of platelet aggregation induced by HLA-related antibodies.
Brandt JT; Julius CJ; Osborne JM; Anderson CL
Thromb Haemost; 1996 Nov; 76(5):774-9. PubMed ID: 8950789
[TBL] [Abstract][Full Text] [Related]
9. Modulation of platelet responses to collagen by Clq receptors.
Peerschke EI; Ghebrehiwet B
J Immunol; 1990 Jan; 144(1):221-5. PubMed ID: 2404063
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a potent platelet aggregation inhibitor from Agkistrodon rhodostoma snake venom.
Huang TF; Wu YJ; Ouyang C
Biochim Biophys Acta; 1987 Sep; 925(3):248-57. PubMed ID: 3620499
[TBL] [Abstract][Full Text] [Related]
11. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
[TBL] [Abstract][Full Text] [Related]
12. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
Taylor FB; Müller-Eberhard HJ
J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
[TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody to the human platelet glycoprotein IIb/IIIa complex induces platelet activation.
Modderman PW; Huisman HG; van Mourik JA; von dem Borne AE
Thromb Haemost; 1988 Aug; 60(1):68-74. PubMed ID: 2973154
[TBL] [Abstract][Full Text] [Related]
14. Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets.
Rijkers M; Schmidt D; Lu N; Kramer CSM; Heidt S; Mulder A; Porcelijn L; Claas FHJ; Leebeek FWG; Jansen AJG; Jongerius I; Zeerleder SS; Vidarsson G; Voorberg J; de Haas M
Haematologica; 2019 Feb; 104(2):403-416. PubMed ID: 30262558
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
[TBL] [Abstract][Full Text] [Related]
16. Platelet prostaglandin production and its implications.
Smith JB; Ingerman CM; Silver MJ
Adv Prostaglandin Thromboxane Res; 1976; 2():747-53. PubMed ID: 983875
[TBL] [Abstract][Full Text] [Related]
17. A monoclonal antibody to the surface membrane of human platelets which inhibits ristocetin- and collagen-induced platelet aggregation reacts with H1 histones of cell nuclei.
Cosgrove L; Alderuccio F; Toh BH; Pedersen J; Holliday A; McKenzie I
Clin Exp Immunol; 1987 Aug; 69(2):409-19. PubMed ID: 3308229
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of collagen-induced fibrinogen binding to human platelets.
Legrand C; Dubernard V; Nurden AT
Biochim Biophys Acta; 1985 Feb; 812(3):802-10. PubMed ID: 3970909
[TBL] [Abstract][Full Text] [Related]
19. Effect of anti-P1A1 antibody on human platelets. I. The role of complement.
Cines DB; Schreiber AD
Blood; 1979 Apr; 53(4):567-77. PubMed ID: 570843
[TBL] [Abstract][Full Text] [Related]
20. Unexpected effects of aurin tricarboxylic acid on human platelets.
Kinlough-Rathbone RL; Packham MA
Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
